As Secretary Azar Heads To Capitol Hill, CSRxP Encourages Lawmakers To Question Budget-Busting $200 Billion Rebate Rule Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Monday ahead of U.S. Department of Health and Human Services Secretary Alex Azar testifying Tuesday on the president’s budget and drug pricing before the U.S. […]
On Thursday, members of the U.S. House Committee on Ways and Means Subcommittee on Health added their voice to the building momentum for action in Washington to bring down the out-of-control price of prescription drugs. Committee members, of both parties, further agreed swift action is needed to crack down on Big Pharma’s anti-competitive tactics and […]
Patients Tell Congress, Paying For Life-Saving Medications Often Means Going Without Basic Needs & Going Into Debt Five patients testified before the U.S. Senate Special Committee on Aging Wednesday to tell their harrowing stories of how skyrocketing drug prices have impacted their lives and their finances. This is the first of three hearings this week […]
On Wednesday, five American patients gave eye-opening testimony to members of the U.S. Senate Special Committee on Aging on the tremendous impact of rising prescription drug prices on their ability to stay healthy and live their lives. Their stories, filled with gut-wrenching sacrifices and dangerous last resorts, were met with vows from members of the […]
FDA Commissioner Was Invaluable Voice In Favor Of Market-Based Solutions To Increase Competition & Lower Drug Prices Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Tuesday praising Food and Drug Administration (FDA) Commissioner Gottlieb for his efforts to support and advance market-based solutions to the prescription drug pricing crisis during […]
Three More Hearings Will Keep Attention On The Impact Of Big Pharma’s Anti-Competitive Tactics Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Tuesday in anticipation of a trio of hearings before Congress this week that will address the crisis of prescription drug prices. “The momentum in Washington to take action […]
On Tuesday, the U.S. Senate Committee on Finance held its second hearing on drug pricing of the new Congress. Committee members, of both parties, used their time to emphasize the real and often gut-wrenching effects of rising drug prices on their constituents and reprimand the executives of the seven large pharmaceutical manufacturers present for their price gouging […]
Washington, D.C. – The Campaign for Sustainable Rx Pricing (CSRxP) released a statement Tuesday after seven pharmaceutical executives testified before the U.S. Senate Committee on Finance in a hearing on rising drug prices: “We thank Chairman Grassley, Ranking Member Wyden and all the members of the committee for their commitment to tackle drug prices in […]
On Tuesday, the U.S. House Committee on Ways & Means held the third hearing of the new Congress in under one month that featured clear, bipartisan consensus on the need for immediate action to bring down the out-of-control prices of pharmaceutical drugs. The commitment expressed by lawmakers on both sides of the aisle, including the […]
The momentum in Congress to act on out-of-control drug prices will continue to build tomorrow, February 12, with a U.S. House Ways and Means Committee hearing entitled, “The Cost of Rising Prescription Drug Prices.” This hearing, the third held by the new Congress on drug pricing, reinforces the strong, bipartisan interest in Washington to answer […]